Upcoming Tocagen IPO To Finance Gene Therapy Clinical Trials … – Benzinga
Benzinga |
Upcoming Tocagen IPO To Finance Gene Therapy Clinical Trials …
Benzinga The biotech firm Tocagen Inc. plans an Initial Public Offering to finance ongoing clinical trials of a technique that uses a weaponized virus to help the … |
